Treatment
Moxifloxacin clinical trials
We’re tracking 20 recruiting studies that include Moxifloxacin, each written for real people, not researchers, below.
Recruiting studies
- NCT07394257Recruiting
Antibiotic injection for hard-to-treat bacterial eye infection
This trial tests if an antibiotic injection directly into the cornea can help when standard eye drops are not working for a stubborn bacterial eye infection.
MinyaAges 20 years+ - NCT06162286RecruitingPhase 3
Comparing two antibiotics for pneumonia in adults
This trial tests a new antibiotic (omadacycline) compared to a standard one (moxifloxacin) for adults with community-acquired pneumonia. The goal is to see if the new drug is as safe and effective.
BeijingAges 18 years+ - NCT05902221RecruitingPhase 3
Rifampicin add-on for knee, hip, or shoulder implant infections
This Phase 3 trial tests whether adding rifampicin improves outcomes for implant infections caused by a specific germ (Cutibacterium acnes) after surgery. If you have such an infection and the germ is susceptible, you may be able to receive a rifampicin-based treatment plan.
AnnecyAges 18 years+ - NCT05331664RecruitingPhase 4
Dropless vitrectomy eye drops for retinal detachment surgery
This trial studies a “dropless” method (fewer post-surgery eye drops) after pars plana vitrectomy, a surgery used to repair a retinal detachment. It may help by improving comfort and simplifying recovery for people having this specific type of retinal detachment repair.
Boston, MassachusettsAges 40 years+ - NCT07305987RecruitingPhase 3
Eye drop study for people after cataract surgery
This study tests a new anti-inflammatory eye drop (PRO-232) in people who had routine cataract surgery on one eye the day before. The goal is to see if it helps control swelling and pain without problems.
Tijuana, Estado de Baja CaliforniaAges 18 years+ - NCT04722978RecruitingPhase 3
Chemo plus moxifloxacin for metastatic triple-negative breast cancer
This trial tests whether adding moxifloxacin (an antibiotic) to standard chemotherapy helps people with metastatic triple-negative breast cancer live longer or respond better. You may qualify if your cancer has the right lab markers and you haven’t had treatment for metastatic disease yet.
Guangzhou, GuangdongAges 18–70 - NCT05398679RecruitingPhase 4
Oral antibiotics versus IV antibiotics after heart infection
This trial compares taking antibiotics by mouth versus receiving antibiotics through a vein (outpatient IV) for an infection of the heart valve. It’s designed to see whether the oral option can work as well and safely, especially after initial treatment and surgery if needed.
Alicante, AlicanteAges 18 years+ - NCT06681688RecruitingPhase 1/Phase 2
Comparing two approaches to prevent cataract surgery complications
This study compares two ways to prevent complications after cataract surgery. One group gets a special combination of eye drops and a steroid injection before surgery, and the other group gets standard care. The goal is to see which approach leads to fewer problems after surgery.
Venice, FloridaAges 18 years+ - NCT02373280Recruiting
7-day tailored treatment to clear H. pylori infection
This trial tests whether a personalized 7-day treatment plan can fully get rid of H. pylori, a common stomach germ. It may help prevent ongoing stomach irritation and ulcers caused by the infection.
Seongnam-si, Gyeonggi-doAges 18–85 - NCT07162116RecruitingPhase 1
Effect of XY0206 on heart rhythm in healthy Chinese volunteers
This trial tests whether a new drug called XY0206 affects the heart's electrical activity (QTc interval). Healthy participants take either XY0206, a placebo, or a control drug to compare effects. It helps ensure the drug is safe for the heart before testing in patients.
Zibo, ShandongAges 18–45 - NCT07212803RecruitingPhase 4
Energy drinks study for young healthy adults
This study looks at how energy drinks affect your heart. It compares the effects of two different energy drinks on heart rate and other heart measures. You will have several short visits where you drink an energy drink and get your heart checked.
Stockton, CaliforniaAges 18–40 - NCT04310930RecruitingPhase 2/Phase 3
Find the best treatment plan for a lung infection
This study looks for the best way to treat Mycobacterium abscessus (MABS), a difficult lung infection. You may join a treatment group, or first join an observation group and possibly move into treatment later if you meet the criteria.
Kogarah, New South WalesAges Any age - NCT05807399RecruitingPhase 2
Step2c trial for new, drug-susceptible lung TB
This Phase 2 study tests treatment for people with newly diagnosed, drug-susceptible pulmonary (lung) tuberculosis (TB). It aims to see whether the study treatment works well and is safe for curing TB.
LambarénéAges 18–65 - NCT06114628RecruitingPhase 2
Finding the best treatment for lung TB (PARADIGM4TB)
This study tests different ways to treat active lung TB that is not resistant to rifampicin. It aims to find the best treatment duration and combination to cure TB and prevent it from coming back.
ChisinauAges 18 years+ - NCT06253715RecruitingPhase 3
Shorter TB treatment for children
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
ChennaiAges birth–9 years - NCT06441006RecruitingPhase 2/Phase 3
Personalized treatment for rifampicin-resistant TB
This trial tests a personalized treatment approach for people with rifampicin-resistant TB that is still sensitive to fluoroquinolones. It aims to find the best combination of medicines based on your specific TB profile.
UlaanbaatarAges 14 years+ - NCT06905522RecruitingPhase 3
Tuberculosis treatment trial for new patients
This trial tests a combination of drugs for people with active tuberculosis who have not been treated before. It aims to find a better way to treat TB, even if the bacteria are resistant to some drugs.
BeijingAges 18–65 - NCT07116915RecruitingPhase 1
Testing a new COPD inhaler for safety and effectiveness
This trial tests a new inhaled medication, HRS-9821, in healthy people and in people with COPD. For COPD patients, the goal is to see how safe and well-tolerated multiple doses are, which could lead to a new treatment option.
Chengdu, SichuanAges 18–75 - NCT02735707RecruitingPhase 3
Adaptive trial for severe pneumonia care in intensive care
This study tests ways to improve treatment for adults with severe pneumonia that lands them in the ICU, adjusting the plan as results come in. It may help your care team find better treatments for lung infection and breathing/heart support needs.
Jacksonville, FloridaAges 18 years+ - NCT07594847RecruitingPhase 1
Safety study of HDM1002 tablets on heart rhythm in healthy adults
This study tests whether a new experimental medication called HDM1002 affects how your heart beats in a healthy population. Researchers want to make sure the drug is safe before testing it in patients with actual medical conditions.
Zibo, ShangdongAges 18–45
What Moxifloxacin is being studied for
Conditions with recruiting Moxifloxacin studies.
Common questions
- Are there clinical trials studying Moxifloxacin?
- Yes. Clin2 currently lists 20 recruiting studies that include Moxifloxacin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Moxifloxacin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Moxifloxacin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Moxifloxacin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.